Literature DB >> 11101572

Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR.

B Farsak1, A Yildirir, Y Akyön, A Pinar, M Oç, E Böke, S Kes, L Tokgözoğlu.   

Abstract

Chlamydia pneumoniae and Helicobacter pylori can cause persistent infections of the respiratory and gastrointestinal tract, respectively. It has been suggested that persistent infection of arteries with these bacteria can contribute to the development of atherosclerosis. The aims of this study were to determine the presence of C. pneumoniae and H. pylori DNA in atherosclerotic plaque samples by PCR and to evaluate the correlation between clinical status and DNA positivity of these bacteria. Eighty-five consecutive patients (mean age, 59 +/- 10; 75 male, 10 female) undergoing coronary artery bypass grafting, carotid endarterectomy, and surgery of the abdominal aorta for atherosclerotic obstructive lesions were included in the study. Forty-six endarterectomy specimens from the atherosclerotic lesions and 39 specimens from healthy regions of the ascending aorta, which were accepted as the control group, were excised. The presence of microorganism DNA in endarterectomy specimens was assessed by PCR. C. pneumoniae DNA was found in 12 (26%) of 46 endarterectomy specimens and none of the healthy vascular-wall specimens (P < 0.001), while H. pylori DNA was found in 17 (37%) of 46 endarterectomy specimens and none of the controls (P < 0.001). Either C. pneumoniae or H. pylori DNA was positive in 23 (50%) of 46 patients and none of the controls (P < 0. 001). Six of the atherosclerotic lesions showed coexistence of both of the microorganism DNAs. The presence of C. pneumoniae and H. pylori DNA in a considerable number of atherosclerotic plaques but their absence in healthy vascular wall supports the idea that they may have a role in the development of atherosclerosis, especially in countries where infection is prevalent and where conventional risk factors fail to explain the high prevalence of atherosclerotic vascular disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11101572      PMCID: PMC87613     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms.

Authors:  F Blasi; F Denti; M Erba; R Cosentini; R Raccanelli; A Rinaldi; L Fagetti; G Esposito; U Ruberti; L Allegra
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

2.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.

Authors:  P Patel; M A Mendall; D Carrington; D P Strachan; E Leatham; N Molineaux; J Levy; C Blakeston; C A Seymour; A J Camm
Journal:  BMJ       Date:  1995-09-16

3.  Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR.

Authors:  N P Mapstone; D A Lynch; F A Lewis; A T Axon; D S Tompkins; M F Dixon; P Quirke
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

4.  Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery.

Authors:  J T Grayston; C C Kuo; A S Coulson; L A Campbell; R D Lawrence; M J Lee; E D Strandness; S P Wang
Journal:  Circulation       Date:  1995-12-15       Impact factor: 29.690

5.  Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.

Authors:  R W Mahley; K E Palaoğlu; Z Atak; J Dawson-Pepin; A M Langlois; V Cheung; H Onat; P Fulks; L L Mahley; F Vakar
Journal:  J Lipid Res       Date:  1995-04       Impact factor: 5.922

6.  Relation of Helicobacter pylori infection and coronary heart disease.

Authors:  M A Mendall; P M Goggin; N Molineaux; J Levy; T Toosy; D Strachan; A J Camm; T C Northfield
Journal:  Br Heart J       Date:  1994-05

7.  Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.

Authors:  J B Muhlestein; E H Hammond; J F Carlquist; E Radicke; M J Thomson; L A Karagounis; M L Woods; J L Anderson
Journal:  J Am Coll Cardiol       Date:  1996-06       Impact factor: 24.094

Review 8.  Infection and inflammation as risk factors for myocardial infarction.

Authors:  M S Nieminen; K Mattila; V Valtonen
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

9.  Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

Authors:  L A Campbell; E R O'Brien; A L Cappuccio; C C Kuo; S P Wang; D Stewart; D L Patton; P K Cummings; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study.

Authors:  M A Mendall; P Patel; L Ballam; D Strachan; T C Northfield
Journal:  BMJ       Date:  1996-04-27
View more
  25 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 2.  Role of Helicobacter pylori infection in pathogenesis of atherosclerosis.

Authors:  Rajesh Vijayvergiya; Ramalingam Vadivelu
Journal:  World J Cardiol       Date:  2015-03-26

3.  No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis.

Authors:  T W Weiss; H Kvakan; C Kaun; M Prager; W S Speidl; G Zorn; S Pfaffenberger; I Huk; G Maurer; K Huber; J Wojta
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

4.  Viral and bacterial DNA in carotid atherosclerotic lesions.

Authors:  S Watt; B Aesch; P Lanotte; F Tranquart; R Quentin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-15       Impact factor: 3.267

5.  Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markers.

Authors:  Ali K Adiloglu; Rabia Can; Cem Nazli; Ahmet Ocal; Oktay Ergene; Gulgun Tinaz; Nesimi Kisioglu
Journal:  Tex Heart Inst J       Date:  2005

6.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

7.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

8.  Infectious burden and carotid plaque thickness: the northern Manhattan study.

Authors:  Mitchell S V Elkind; Jorge M Luna; Yeseon Park Moon; Bernadette Boden-Albala; Khin M Liu; Steven Spitalnik; Tanja Rundek; Ralph L Sacco; Myunghee C Paik
Journal:  Stroke       Date:  2010-01-14       Impact factor: 7.914

9.  Is the perceived association between Chlamydia pneumoniae and vascular diseases biased by methodology?

Authors:  Boulos Maraha; Hans Berg; Marjolein Kerver; Steef Kranendonk; Jaap Hamming; Jan Kluytmans; Marcel Peeters; Anneke van der Zee
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 10.  Role of dental plaque, saliva and periodontal disease in Helicobacter pylori infection.

Authors:  Pradeep S Anand; Kavitha P Kamath; Sukumaran Anil
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.